36 filings
8-K
PRNB
Principia Biopharma Inc.
28 Sep 20
Completion of Acquisition or Disposition of Assets
8:42am
8-K
PRNB
Principia Biopharma Inc.
17 Aug 20
Sanofi to acquire Principia Biopharma
6:31am
8-K
PRNB
Principia Biopharma Inc.
6 Aug 20
Principia Biopharma Reports Second Quarter 2020
4:17pm
8-K
PRNB
Principia Biopharma Inc.
26 Jun 20
Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis
4:05pm
8-K
PRNB
Principia Biopharma Inc.
12 Jun 20
Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
6:10am
8-K
9uqt72qd
9 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
chw knv28ey79
6 May 20
Principia Biopharma Reports First Quarter 2020 Financial Results
4:15pm
8-K
1zbusv
24 Apr 20
Other Events
4:05pm
8-K
ozlrsa13 xu3ctrm
10 Mar 20
Principia Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:11pm
8-K
g8erajze5lnu4degb4b
7 Feb 20
Other Events
12:00am
8-K
j1qfwmivjxw3bo4s
10 Jan 20
Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases
4:30pm
8-K
0r5xyx k2yyoa
9 Dec 19
Principia Presents Consistent Positive Data of PRN1008
6:09am
8-K
6411l
5 Nov 19
Principia Biopharma Reports Third Quarter Financial Results
4:10pm
8-K
i0suvtwic06kww2ryab7
18 Oct 19
Entry into a Material Definitive Agreement
4:14pm
8-K
ku7jd mfgz3y4g
15 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
7:09am
8-K
15tjqo
10 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 from its
7:00am
8-K
df3px
30 Aug 19
Departure of Directors or Certain Officers
4:10pm
8-K
vntqghhtfq5d8irj
8 Aug 19
Principia Biopharma Reports Second Quarter Financial Results
4:11pm
8-K
gudkuzn4ntmheceb641m
14 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
ih0w48 d5f8edba
15 May 19
Principia Biopharma Announces First Patient Dosed in Sanofi’s Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone
9:01am